Abstract
The participation of the psychiatrist in the management of erectile dysfunction (ED) is focused on three types of patients based on the origin of the dysfunction: (1) patients with functional or psychogenic ED, (2) patients with mixed, organic psychogenic ED, and (3) patients with ED and active psychopathology. The second group is influenced by three psychological factors: perpetuating factors, aggravating factors, and accompanying factors. The main psychopathological disorders that interfere directly with the erectile mechanism are depressive disorders (18–35%), anxiety disorders (37%), obsessive–compulsive disorder, psychotic disorders (46–47%), and the antipsychotic medications used to treat these disorders. The diagnostic proposal includes psychological and sexologic evaluation and differential diagnosis. The therapeutic proposal includes the basic principles of sex therapy in the model of behavioral-cognitive therapy (eg, prohibition of intercourse, sensate focus, voluntary loss of erections, no expectations about response), pharmacological therapy (eg, sildenafil, intracavernous injection of vasoactive drugs), and a combination of both therapies.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 8 print issues and online access
$259.00 per year
only $32.38 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Feldman HA et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994; 151: 54–61.
Teusch L et al. Different patterns of sexual dysfunctions associated with psychiatric disorders and psychopharmacological treatment. Results of an investigation by semistructured interview of schizophrenic and neurotic patients and methadone-substituted opiate addicts. Pharmacopsychiatry 1995; 28: 84–92.
Montejo AL, Llorca G, Izquierdo JA, Rico-Villademoros F . Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction. J Clin Psychiatry 2001; 62: 10–21.
LoPiccolo J, Steger JC . The sexual interaction inventory: a new instrument for assessment of sexual dysfunction. Arch Sex Behav 1974; 3: 585–595.
Rust J, Golombok S . The GRISS: a psychometric instrument for the assessment of sexual dysfunction. Arch Sex Behav 1986; 15: 157–165.
Bobes J et al. Evaluating changes in sexual functioning in depressed patients: sensitivity to change of the CSFQ. J Sex Marital Ther 2002; 28: 93–103.
Hargreave T . Efficacy of sildenafil in the treatment of erectile dysfunction in patients with depression. Presented at the Annual Congress of the Collegium Internationale Neuro-Psychopharmacologicum, Glasgow, UK 1998.
Nurnberg HG et al. Efficacy of sildenafil citrate for the treatment of erectile dysfunction in men taking serotonin reuptake inhibitors. Am J Psychiatry 2001; 158: 1926–1928.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Farre, J., Fora, F. & Lasheras, M. Specific aspects of erectile dysfunction in psychiatry. Int J Impot Res 16 (Suppl 2), S46–S49 (2004). https://doi.org/10.1038/sj.ijir.3901243
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ijir.3901243
Keywords
This article is cited by
-
Functional insights into aberrant brain responses and integration in patients with lifelong premature ejaculation
Scientific Reports (2017)
-
Effect of sildenafil on the activity of some antidepressant drugs and electroconvulsive shock treatment in the forced swim test in mice
Naunyn-Schmiedeberg's Archives of Pharmacology (2017)
